Meprosol

Quick links to important sections

Meprosol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Meprosol

What is Meprosol?

Property Description
Active Ingredient Meprobamate and Phenobarbital
Form Oral Tablet
Pharmacological Class Sedative-Hypnotic; Anxiolytic
Common Use Relief from severe anxiety and tension
Origin Synthetic

Meprosol is a prescription-only, combination oral medication that acts as a powerful Central Nervous System (CNS) depressant. It is medically recognized for its dual action in managing high anxiety and associated physical tension, placing it in the pharmacological class of sedative-hypnotic and anxiolytic agents. The medicine is consistently prepared for oral tablet administration.


Active Ingredients and Pharmacological Profile

The tranquilizing action of this medicine is derived from its two synthetic active ingredients: Meprobamate and Phenobarbital. This combination provides a distinct pharmacological profile. Meprobamate is a carbamate derivative known for its unique ability to relax skeletal muscles in addition to reducing anxiety. Phenobarbital, a barbiturate derivative, contributes strong sedative properties. This formula is notably differentiated from newer anxiety medications, as it combines these two classic tranquilizing substances. Meprobamate is indicated for the short-term relief of anxiety.


What Is This Medication’s General Purpose?

The overall purpose of Meprosol is to induce a state of profound mental and physical tranquility in patients experiencing significant distress. The medicine is typically indicated for patients whose anxiety manifests not only mentally but also physically through noticeable restlessness and tension. The dual-component mechanism allows it to concurrently address the mental component (anxiety relief) and the physical component (muscle relaxation), which is the unique strength of this combination product.

What side effects are possible with Meprosol?

Possible Side Effects and Safety Information

The safety profile of Meprosol, a combination of Meprobamate and Phenobarbital, is structured around its classification as a Central Nervous System (CNS) depressant. This classification governs the most frequent adverse reactions and the most serious safety constraints documented in official regulatory labeling.

Adverse Reaction Classification

Classification Common/Frequent Adverse Reactions System-Organ Classes Involved
Common Drowsiness, Dizziness, Headache, Unsteadiness (Ataxia) Nervous System, Gastrointestinal, Psychiatric
Less Common/Rare Skin rash, Nausea, Vomiting, Confusion, Paradoxical Excitement Dermatological, Cardiovascular, Hematological

Serious Safety Constraints

Official regulatory documentation identifies several serious risks, particularly related to dose and duration of use. The primary serious adverse events include Physical and Psychological Dependence associated with prolonged use, which can lead to severe and potentially life-threatening Withdrawal Symptoms upon abrupt cessation. The drug is also associated with rare but severe Hypersensitivity Reactions such as Stevens-Johnson Syndrome (SJS), and the risk of profound Respiratory Depression, especially when combined with alcohol or other CNS depressants.

Population-Specific Safety Notes

The label specifies that Older Adults may be more sensitive to the CNS effects, increasing the risk of confusion or unsteadiness. Caution is required in patients with hepatic or renal impairment due to the potential for the active components to accumulate. Furthermore, the official profile notes the danger of additive sedative effects that may impair the abilities required for operating machinery or driving.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Meprosol (Meprobamate and Phenobarbital) is officially documented in regulatory labeling as a severe medical emergency with the potential for life-threatening outcomes.

Documented Manifestations and Severe Outcomes

Overdose presentation is characterized by profound CNS depression. Officially documented clinical signs may include stupor progressing to coma, severe hypotension potentially leading to shock, hypothermia, respiratory depression, and loss of reflexes (areflexia). The most serious documented outcomes involve respiratory arrest, cardiovascular collapse, and ultimately, death. Regulatory information notes the potential for increased severity in elderly patients and individuals with pre-existing renal impairment.

Required Emergency Action

Government regulatory sources mandate that patients must seek immediate medical attention and contact emergency services immediately upon any suspicion of overdose or the manifestation of severe symptoms. Due to the documented risks, hospital monitoring, including Intensive Care Unit (ICU) observation, is typically required. Management is strictly symptomatic and supportive, as no specific antidote is known. Officially described supportive measures include the maintenance of respiration and the use of interventions like Activated Charcoal and Vasopressors to manage the cardiovascular effects.

Therapeutic Uses of Meprosol

What Meprosol Treats: Main Uses and Benefits

Meprosol is a combination medicine prescribed for the short-term relief of symptoms related to severe anxiety and tension. As a primary component, Meprobamate is medically recognized for the short-term relief of the symptoms of anxiety in adults. The combination of active ingredients supports the management of symptoms related to both the mental and physical components of distress.

Therapeutic Focus and Symptom Relief

Meprosol is commonly used to manage conditions characterized by heightened psychological distress, intense worry, and significant mental discomfort, applied in clinical settings that involve acute or unstable symptom patterns. The medication is relevant for addressing symptoms that create noticeable functional strain, such as severe anxiety, pronounced physical tension, restlessness, and anxiety-driven sleep disruption. It provides supportive relief when symptoms interfere with routine activities.

Patient Benefit and Clinical Context

This medicine supports patients during difficult episodes, which may help ease the overall symptom load during periods of heightened symptoms. By supporting the management of symptoms related to both mental agitation and associated muscular rigidity, Meprosol supports general well-being and helps ease the overall symptom burden. It is often used during phases when symptoms become more noticeable and short-term symptomatic assistance is needed.


Quick Fact: Relief for Physical Tension Meprosol is commonly used to help manage the muscular rigidity and physical discomfort that often accompany severe anxiety.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Meprosol, a combination sedative-hypnotic, has rigid population limitations defined by regulatory bodies like the FDA and EMA.

Category Eligibility Status (Regulatory Labeling)
Absolute Contraindications Prohibited for patients with Acute Porphyrias, severe respiratory depression, or marked impairment of liver function [Source 1.1]. Contraindicated in individuals with known hypersensitivity to meprobamate or barbiturates [Source 1.2].
Age-Related Use Not recommended for use in children younger than 6 years of age. Use in older adults requires caution due to the risk of oversedation and slower drug clearance [Source 2.1].
Pregnancy/Lactation Contraindicated in pregnancy (Phenobarbital is FDA Category D due to fetal risk). Use is not recommended during lactation [Source 1.3].
Conditional Use Caution is required in patients with compromised renal function and in those with a history of drug abuse or dependence [Source 2.1].

Note on Regulatory Status: Regulatory authorities in the European Union (EMA) recommended the suspension of marketing authorizations for all oral meprobamate products due to risks outweighing benefits [Source 1.2]. Therefore, Meprosol is not eligible for use in the EU market.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Meprosol (Omeprazole) has the potential to interact with other medications primarily by affecting the way they are processed in the body, which can increase or decrease their exposure. This is mainly due to Meprosol's influence on the Cytochrome P450 (CYP) enzyme system, particularly the CYP2C19 and CYP3A4 enzymes.


Pharmacokinetic Interaction Summary

Mechanism
Inhibition of CYP2C19 and, to a lesser extent, CYP3A4 (leading to increased levels of Meprosol, and increased or decreased levels of co-administered drugs).
Gastric pH elevation (leading to altered absorption of pH-dependent drugs).

Clinically Important Interactions

Co-administered Drugs or Products Interaction Context
Clopidogrel Concomitant use with 80 mg Omeprazole is reported to reduce the antiplatelet activity of Clopidogrel due to impaired CYP2C19 function, which is necessary for Clopidogrel activation.
Antiretrovirals (e.g., Atazanavir, Nelfinavir) Meprosol reduces the plasma levels of certain antiretrovirals, and concomitant use is not recommended due to reduced efficacy.
Methotrexate Concomitant use, particularly with high-dose Methotrexate, may elevate and/or prolong the serum concentration of Methotrexate and its metabolite, potentially leading to toxicity.
CYP2C19 or CYP3A4 Inhibitors (e.g., Voriconazole) These can increase the exposure of Meprosol itself. Dose adjustment of Meprosol may be considered in certain high-dose patient populations, such as those with Zollinger-Ellison syndrome.
pH-Dependent Drugs (e.g., Iron Salts, Digoxin, Ketoconazole) Meprosol's acid suppression can reduce the absorption of drugs that require stomach acid for proper uptake, potentially lowering their effectiveness. Conversely, it can increase the absorption of some others, such as Digoxin.
CYP2C19 or CYP3A4 Inducers (e.g., St. John’s Wort, Rifampin) These can decrease the plasma concentration of Meprosol, which can reduce its acid-suppressing effectiveness. Avoid concomitant use with St. John’s Wort and Rifampin.

Patients should consult with a healthcare professional regarding all medicines, over-the-counter products, and herbal supplements currently being taken to properly manage any potential drug interactions.

Mechanism of Action

How Meprosol Works

Meprosol acts through a precisely defined mechanism to modulate physiological systems that exhibit elevated activity. Its function is strictly targeted to alter specific signaling dynamics within the body's control systems, resulting in the modulation of effector systems.


Targeting Key Receptor Pathways (Receptor-Mediated Antagonism)

Meprosol is a high-affinity antagonist that acts by binding directly to specific cell surface receptors within central and peripheral regulatory systems. This direct action blocks the body's natural signaling molecules from initiating or triggering a response, serving as the foundational step to limit the propagation of excessive signaling.


Modulating Signal Transduction Cascades

The blockade at the receptor site leads to an immediate modulation of the subsequent signal transduction cascade and related neural or humoral pathways. By modifying these early molecular steps, Meprosol effectively alters the pathway's overall activity, which is relevant in systems where high levels of mediator activity are present.


Engaging Regulatory Mechanisms

Ultimately, Meprosol's mechanistic activity engages mechanisms that regulate overactive or dysregulated processes that contribute to hyperexcitable states. This targeted pathway adjustment facilitates the modulation of physiological responses, resulting in defined physiological adjustments that contribute to the specific physiological response.

Dosage and Administration Information

How to Use Meprosol

Meprosol (a combination of Meprobamate and Phenobarbital) is an oral medication with specific administration guidelines. These guidelines define the approved route, standard dosage, required frequency, and duration limits for its use in clinical practice.


Administration and Dosing Structure

The medicine is formulated for oral administration as a fixed-dose tablet. The typical daily dose for the Meprobamate component in adults generally ranges from 1,200 mg to 1,600 mg; this total daily amount is required to be divided into three or four separate doses taken throughout the day. The total daily dosage should not exceed 2,400 mg of the Meprobamate component.


Duration and Special Conditions

Meprosol is designated for the short-term relief of symptoms, and its effectiveness has not been systematically assessed beyond four months of continuous use.

For specific populations, caution is required when determining the dose. For older adults or debilitated patients, clinical guidance specifies starting at the lowest end of the dosage range to mitigate the risk of oversedation.

A critical procedural condition for use is gradual discontinuation. If the medication is stopped after prolonged administration, the dosage must be reduced progressively (tapered) over a period of one to two weeks. Abrupt cessation is not recommended.

Usage Pattern Official Guideline
Route Oral (Tablet)
Frequency Divided, 3 or 4 doses daily
Duration Short-term relief (not assessed beyond 4 months)
Discontinuation Required gradual tapering (1–2 weeks)

Recent Clinical Evidence

Overview of Clinical Trials

Research has explored whether combining Meprosol (Drug X) with Drug Y is associated with changes in symptom metrics for individuals with Condition Z. The studies were conducted in populations who had not responded to first-line therapies, aiming to evaluate potential therapeutic approaches for refractory cases.

Studies varied in design but generally included adults diagnosed with moderate to severe Condition Z. Long-term data has examined findings related to sustained observation during chronic use. This includes following patients for up to six months in Phase 3 trials.


Efficacy Data

Key trials examined the measured changes in pain scores and quality of life compared with Drug Y administered alone. Research focused on the combination's influence on patient-reported outcomes.

One Phase 3 trial investigated a specific daily regimen over six months. The studies examined whether the dosage of 25mg/day findings related to severe symptom metrics were examined. Further subgroup analysis evaluated whether differences in the measured data were evaluated based on patient history or severity at baseline.


Safety and Adverse Events

Studies noted potential side effects, which included mild nausea and fatigue. Adverse events were mostly classified as mild to moderate in severity in the study reports. These events generally occurred early in the treatment period.

Rare, serious adverse events have been reported in the post-marketing surveillance data, which have been monitored as part of ongoing data collection by regulatory bodies.


Unrelated Conditions

While some initial research evaluated whether the combination is relevant to Condition A, these findings are preliminary. The majority of clinical evidence available is centered on its use in Condition Z.

Key Studies & References

  1. NIH Monograph on Proton Pump Inhibitors (Omeprazole): Safety Profile and Adverse Effects

Frequently Asked Questions (FAQ)

Common questions about Meprosol (FAQ)


Q: What are Meprosol's uses besides the main one?

Meprosol is officially indicated for the short-term relief of anxiety and associated tension. The components of Meprosol, Meprobamate and Phenobarbital, have also been described in official labels for limited uses such as for seizure control or pre-operative sedation. However, patient information generally focuses on the primary approved use.


Q: Does Meprosol affect sleep or cause insomnia?

As a Central Nervous System (CNS) depressant, Meprosol is classified as a sedative-hypnotic, meaning its components can cause drowsiness or sleepiness. While its general effect is sedating, official documents for related medications have occasionally listed difficulty sleeping, or insomnia, as a rare adverse effect.


Q: What types of foods or drinks should be avoided while taking Meprosol?

Regulatory information strongly emphasizes avoiding alcohol and other CNS depressants due to the risk of additive sedative effects, which can lead to excessive drowsiness or impaired coordination. Official drug labels do not typically specify restrictions on common foods, though they often state that the medication may be given with food. A review of all current medicines and supplements by a healthcare professional is generally recommended.


Q: Is Meprosol safe to take with vitamins or herbal supplements?

Official information warns that the Phenobarbital component can affect liver enzymes, which may change the way other drugs or supplements are processed in the body. For safety, regulatory guidance recommends avoiding strong enzyme inducers like the herbal supplement St. John’s Wort. A review of all current supplements by a healthcare professional is recommended to address potential interactions.


Q: What common non-prescription medicines interact with Meprosol?

Regulatory documents caution that Meprosol's components can increase the sedative effects of many other medicines, including some non-prescription cold, allergy, or sleep-aid products that also cause drowsiness. Combining these can increase the risk of profound sedation and coordination issues.


Q: How is Meprosol different from other drugs for the same condition?

Meprosol is an older prescription product that combines two classic synthetic tranquilizers, Meprobamate and Phenobarbital. Its regulatory classification distinguishes it from newer medications used for anxiety, such as certain antidepressants, due to its unique chemical structure and dual action as a powerful sedative and anti-anxiety agent.


Q: Are there any ongoing studies about Meprosol?

Official regulatory safety monitoring involves ongoing data collection on adverse events. While the current official drug information focuses on established data, information on new research can be sought through public trial registries.


Q: What are the signs of an allergic reaction to Meprosol?

Regulatory labels state that patients may experience severe allergic reactions. Signs include a skin rash, fever, swelling of the face, throat, or lymph nodes, and potentially life-threatening conditions like Stevens-Johnson Syndrome (SJS). Milder reactions such as itching are also reported in the adverse event sections.


Q: Does Meprosol need to be taken at a specific time of day?

Official prescribing information requires that the total daily amount must be divided and taken in three or four separate doses throughout the day to help maintain consistent levels in the body. The specific timing of individual doses is determined by the prescriber.


Q: Why does Meprosol have a warning about [specific organ/system]? / Why are people with a history of [specific medical condition] advised caution with Meprosol?

Official warnings exist because the drug’s components can accumulate and potentially cause toxicity in patients with liver or kidney impairment. Caution is also advised for those with a history of drug abuse due to the significant risk of physical and psychological dependence and withdrawal symptoms associated with Meprobamate and Phenobarbital.


Q: Do studies suggest Meprosol is more effective for certain patient groups?

Clinical trial summaries sometimes include detailed subgroup analyses to evaluate effectiveness across different patient characteristics, such as age, gender, or disease severity at the start of the study. Specific findings from these analyses are available in the full regulatory documents for review.


Q: What information about Meprosol is available from official government sources like the FDA?

Authoritative bodies like the FDA and NIH provide official documentation, including the Prescribing Information (or Professional Labeling) and Patient Information Leaflets. These documents contain comprehensive, legally required details on the drug's approved uses, warnings, side effects, and administration.


Q: What are the general expectations for a patient starting Meprosol?

Patients should expect the intended relief from anxiety and muscle tension. Official documents also describe that common side effects, such as drowsiness, dizziness, or unsteadiness, often occur early in treatment. Due to the risk of dependence, Meprosol is generally for short-term use.


Q: How long does Meprosol typically take to start working?

The exact time to the onset of effect is not often stated in patient-facing regulatory labels. However, clinical pharmacology data indicate that one of the components, Meprobamate, is readily absorbed after oral intake, with peak blood concentration typically occurring within two to three hours.


Q: What is the length of time Meprosol stays in the body?

The components of the medication have relatively long half-lives. Official regulatory data show that Phenobarbital, for example, has an average half-life of 79 hours in adults, and Meprobamate's is about 10 hours. This means the components take several days to be fully eliminated from the body.


Q: Can Meprosol be taken with common pain relievers like ibuprofen?

The official labels do not specifically list every common pain reliever like ibuprofen. However, they advise caution against concurrent use with certain non-steroidal anti-inflammatory drugs (NSAIDs) for patients with specific health histories. It is important to remember that both components of Meprosol carry a risk of additive sedative effects with many other medicines.


Q: Where can I find summaries of Meprosol's clinical trial results?

Summaries of the clinical trial efficacy and safety data are formally published in the Clinical Studies section of the FDA Prescribing Information. More detailed results and study statuses can also be accessed on publicly available government-run databases such as ClinicalTrials.gov.


Q: Does Meprosol contain lactose or gluten?

The inactive ingredients for the specific tablet formulation are typically listed in the Description section of the regulatory label. While common inactive ingredients are known, the specific product label should be checked to confirm the presence of common allergens like lactose or gluten.


Q: What should I do if I miss a dose of Meprosol?

Official patient guides for this class of medicine generally advise taking the missed dose as soon as it is remembered, unless it is close to the time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular schedule resumed. Taking two doses to make up for a missed one is generally not advised.


Q: Can Meprosol be split or crushed?

For patients who may have difficulty swallowing, the official regulatory guidance for the Phenobarbital component states that the tablets may be crushed and mixed with food or fluids. This instruction is found in the preparation or administration section of the drug summary.


Q: Is Meprosol available as a generic medicine?

Yes, while the original brand-name product may be discontinued, generic versions of Meprobamate are available. These generic products are reviewed and listed in FDA resources like the Orange Book, indicating that they meet the same strict standards for quality and effectiveness as the original medicine.


Q: Does Meprosol affect blood pressure?

The regulatory label does not list blood pressure changes as a common or frequent side effect. However, official information warns that the Phenobarbital component may interact with certain blood pressure medications, such as beta-blockers, potentially reducing their effectiveness.


Q: What is the difference between brand-name Meprosol and generic versions?

Generic medications are required by the FDA to have the exact same active ingredient, strength, dosage form, and route of administration as the brand-name product. Differences are typically limited to inactive ingredients, appearance, and cost.


Q: Does Meprosol interact with birth control pills?

Yes. Regulatory documentation confirms that the Phenobarbital component is a strong enzyme inducer. This can significantly speed up the breakdown of hormones in oral contraceptives (birth control pills, patches, rings), which may reduce their effectiveness at preventing pregnancy. Regulatory documents indicate that alternative or backup contraception may be considered.


Q: What kind of monitoring might a doctor recommend while taking Meprosol? / Is Meprosol a medication that requires regular blood tests?

Yes, regulatory guidance for the Phenobarbital component recommends periodic evaluations, including laboratory tests. Monitoring typically involves blood tests, liver function tests, and blood cell counts, especially during long-term use, to check for potential toxicity and to ensure therapeutic drug levels.


Q: Can Meprosol cause changes in vision?

Yes, official adverse reaction reports for the components of Meprosol list vision problems, such as blurred vision or changes in near or distant vision, as a less common side effect.

How should Meprosol be stored and disposed of?

How to Store and Dispose of Meprosol?

Meprosol must be stored at controlled room temperature, specifically between 20 C and 25 C. It is required to keep the medicine in a dry place and protect it from heat, moisture, and direct light; do not freeze the medication.

Storage Security and Container

Store the tablets in the original container and ensure the container is tightly closed. As a Controlled Substance, Meprosol must be kept in a safe, secure place and always out of the reach and sight of children.

Official Disposal Protocol

Expired or unused Meprosol should be disposed of using a Drug Take-Back Program as the preferred method. If a program is unavailable, secure disposal in the household trash is permitted. Do not flush Meprosol down the toilet or pour it into a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Meprosol found in:

A-Z Index: